KOVINA THERAPEUTICS
Kovina Therapeutics operates as a pre-clinical biotechnology company aims to discover a non-surgical, medical treatment for Human Papillomavirus (HPV) infections and cancers.
KOVINA THERAPEUTICS
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2020-01-01
Address:
Indianapolis, Indiana, United States
Country:
United States
Website Url:
http://www.kovina.com
Status:
Active
Total Funding:
2 M USD
Technology used in webpage:
Microsoft Exchange Online Office 365 Mail Webflow Webflow Hosting
Similar Organizations
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Cancer Institute
National Cancer Institute investment in Grant - Kovina Therapeutics
BioCrossroads
BioCrossroads investment in Seed Round - Kovina Therapeutics
IU Ventures
IU Ventures investment in Seed Round - Kovina Therapeutics
Elevate Ventures
Elevate Ventures investment in Seed Round - Kovina Therapeutics
Official Site Inspections
http://www.kovina.com Semrush global rank: 5.91 M Semrush visits lastest month: 1.4 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Kovina Therapeutics"
Kovina Therapeutics | Antiviral Therapeutics for HPV Cancers and …
Kovina Therapeutics Inc. announced receipt of a Small Business Innovation Research (SBIR) one-year Phase I award from the National Institute of Allergy and Infectious …See details»
Kovina Therapeutics - Crunchbase Company Profile & Funding
Organization. Kovina Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Kovina Therapeutics operates as a …See details»
(includes ICORPS) - Elevate
Kovina Therapeutics is an early-stage drug discovery company focused on stopping HPV premalignant infections before cancer develops and treating ... Leads the organization with 30 …See details»
Kovina Therapeutics Company Profile 2024: Valuation, …
Kovina Therapeutics has raised $2.33M. Who are Kovina Therapeutics’s investors? National Institute of Dental and Craniofacial Research, National Institute Of Allergy and Infectious Diseases, National Cancer Institute, …See details»
Biotechnology Startup Receives Funding to Advance HPV Cancer …
INDIANAPOLIS (Oct. 20, 2021) – Kovina Therapeutics announced the recent close of a $2 million seed round of financing led by Elevate Ventures.Other participating investors include …See details»
Kovina Therapeutics - LinkedIn
Kovina Therapeutics | 265 followers on LinkedIn. Kovina Therapeutics is a preclinical stage biotechnology company developing first-in-class antiviral HPV therapeutics | Kovina Therapeutics is a ...See details»
Kovina Therapeutics - Funding, Financials, Valuation & Investors
Kovina Therapeutics operates as a pre-clinical biotechnology company. Kovina Therapeutics is funded by 6 investors. National Institute of Dental and Craniofacial Research (NIDCR) and …See details»
Kovina Therapeutics - VentureRadar
Kovina Therapeutics is a preclinical stage biotechnology company developing first-in-class antiviral therapeutics specifically designed to treat cancers and pre-malignant infections …See details»
Sue Mahony, Ph.D. | Kovina Therapeutics, Inc
Dr. Mahony joined the Kovina board as a director in June 2021. From 2011 until her retirement in August 2018, she served as Senior Vice President and President of Lilly Oncology and was a member of the executive committee at …See details»
Kovina Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Kovina Therapeutics Inc. of Indianapolis, IN. Get the latest business insights from Dun & Bradstreet.See details»
Kovina Therapeutics – Indiana Health Industry Forum - IHIF
Sep 28, 2023 www.kovina.com Indianapolis, IN Contact: Kristin Sherman, CEO Kovina Therapeutics is a preclinical drug discovery company focused on stopping human …See details»
Kovina Therapeutics Receives National Cancer Institute Grant to …
Jun 27, 2022 Kovina Therapeutics is a biotechnology company developing first-in-class antiviral therapies to treat cancers and pre-malignant infections caused by Human Papillomavirus (HPV).See details»
IU-Affiliated Biotechnology Startup will use Seed Funding ... - Kovina
INDIANAPOLIS — With the support of IU Ventures and the IU Innovation and Commercialization Office, Kovina Therapeutics, a preclinical biotechnology startup seeking to develop new …See details»
Kovina Therapeutics Receives Grant from NIH to Advance Human ...
Kovina Therapeutics Receives Grant from NIH to Advance Human ...See details»
IU-affiliated biotechnology startup will use seed funding toward ...
FOR IMMEDIATE RELEASE Nov. 15, 2021 INDIANAPOLIS — With the support of IU Ventures and the IU Innovation and Commercialization Office, Kovina Therapeutics, a preclinical …See details»
Research programme: antiviral therapeutics - Kovina Therapeutics
01 Nov 2022 Kovina Therapeutics receives SBIR one-year phase I grant from National Institute of Dental and Craniofacial Research for antiviral therapeutics development in Oropharyngeal …See details»
Kovina Therapeutics Receives NIH Grant to Develop Human …
Nov 1, 2022 Kovina Therapeutics is a biotechnology company developing first-in-class antiviral therapies to treat cancers and premalignant infections caused by Human Papillomavirus …See details»
Fritz French | Kovina Therapeutics, Inc
Earlier in his career, he held numerous marketing, sales, international and general management positions for Eli Lilly’s Medical Device Division and Guidant. Mr. French currently serves on the …See details»
Kovina Therapeutics Receives Grant from NIH to Advance Human ...
Sep 12, 2022 Kovina Therapeutics is a biotechnology company developing first-in-class antiviral therapies to treat cancers and premalignant infections caused by Human Papillomavirus (HPV).See details»
Press Releases - Kovina
Kovina is a preclinical biotechnology company developing first-in-class antiviral therapies to treat cancers and pre-cancerous malignancies associated with Human Papillomavirus (HPV). A …See details»